浙江医药

- 600216

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2022  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012 
浙江医药(600216) 利润表
单位:万元
报表日期2022-09-302022-06-302022-03-312021-12-312021-09-30
一、营业总收入612,387.31411,766.80218,419.21912,909.45681,165.20
营业收入612,387.31411,766.80218,419.21912,909.45681,165.20
二、营业总成本549,860.79360,091.35188,401.42793,230.07596,686.20
营业成本393,326.23258,892.94135,851.33539,973.61397,712.13
营业税金及附加4,558.092,870.401,843.167,517.175,467.47
销售费用70,683.5144,931.9423,337.61112,941.6993,979.54
管理费用29,471.3819,019.678,190.3342,800.7325,087.12
财务费用-3,717.81-1,131.211,879.209,310.985,175.19
研发费用55,539.3835,507.6117,299.7880,685.9069,264.75
资产减值损失----------
公允价值变动收益-2,573.59-2,491.27-2,602.825,172.645,537.32
投资收益2,766.26666.401,708.944,181.464,393.65
其中:对联营企业和合营企业的投资收益-120.40-192.65-178.34-423.98137.87
汇兑收益----------
三、营业利润50,154.5441,815.7726,801.77117,943.6787,104.61
加:营业外收入153.2447.3814.13103.9693.87
减:营业外支出1,325.28846.81266.282,694.471,746.74
其中:非流动资产处置损失----------
四、利润总额48,982.4941,016.3426,549.62115,353.1685,451.74
减:所得税费用13,192.569,785.795,065.1726,897.5616,860.74
五、净利润35,789.9331,230.5521,484.4488,455.6068,591.01
归属于母公司所有者的净利润48,445.4339,058.7726,054.32104,531.9975,061.48
少数股东损益-12,655.50-7,828.22-4,569.87-16,076.39-6,470.48
六、每股收益
基本每股收益(元/股)0.51000.41000.27001.09000.7800
稀释每股收益(元/股)0.51000.41000.27001.09000.7800
七、其他综合收益-129.62-294.49-410.10-1,553.04-886.91
八、综合收益总额35,660.3230,936.0621,074.3486,902.5767,704.10
归属于母公司所有者的综合收益总额48,286.0938,766.6425,676.35103,091.3374,241.93
归属于少数股东的综合收益总额-12,625.78-7,830.57-4,602.01-16,188.77-6,537.83
下载全部历史数据到excel中 返回页顶